High incidence of cytokine release syndrome in patients with advanced NSCLC treated with nivolumab plus ipilimumab. Shiraishi Y, Sekino Y, Horinouchi H, Ohe Y, et al. Ann Oncol 2023;34:1064-1065.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shiraishi Y, Sekino Y, Horinouchi H, Ohe Y, et al. High incidence of cytokine release syndrome in patients with advanced NSCLC treated with nivolumab plus ipilimumab. Ann Oncol 2023;34:1064-1065.
PMID: 37666485